SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-17-000768
Filing Date
2017-04-19
Accepted
2017-04-19 16:43:18
Documents
35
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q immg_10q.htm 10-Q 137979
2 CERTIFICATION immg_ex311.htm EX-31.1 7816
3 CERTIFICATION immg_ex312.htm EX-31.2 7960
4 CERTIFICATION immg_ex321.htm EX-32.1 3311
5 CERTIFICATION immg_ex322.htm EX-32.2 3165
  Complete submission text file 0001640334-17-000768.txt   833019

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT immg-20170228.xml EX-101.INS 70417
7 XBRL TAXONOMY EXTENSION SCHEMA immg-20170228.xsd EX-101.SCH 14559
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immg-20170228_cal.xml EX-101.CAL 13830
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immg-20170228_def.xml EX-101.DEF 18153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE immg-20170228_lab.xml EX-101.LAB 99196
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immg-20170228_pre.xml EX-101.PRE 70057
Mailing Address 10411 MOTOR CITY DR., SUITE 750 BETHESDA MD 20817
Business Address 10411 MOTOR CITY DR., SUITE 750 BETHESDA MD 20817 (443) 961-1185
IMMAGE BIOTHERAPEUTICS CORP. (Filer) CIK: 0001564273 (see all company filings)

IRS No.: 455538945 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 333-185368 | Film No.: 17770422
SIC: 2834 Pharmaceutical Preparations